LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1

Arbyn Marc

Last name
-
First name
-
Country
-
  • Quel dépistage pour le cancer du col ?

    17 p. ill;, On sait aujourd’hui avec certitude qu’il existe un lien de cause à effet entre le cancer du col de l’utérus et la présence du papillomavirus (HPV), transmis par voie sexuelle. Le KCE (Centre Fédéral d’Expertise des Soins de Santé) a établi, en collaboration avec l’Institut scientifique de Santé Publique et le Registre du Cancer, qu’un dépistage basé sur la détection de la présence du virus serait plus efficace que l’actuel frottis (aussi appelé Pap-test) pour protéger les fe...

    Welke screening voor baarmoederhalskanker ?

    17 p. ill;, Er bestaat een duidelijk verband tussen baarmoederhalskanker en de aanwezigheid van een lokale infectie met het humaan papillomavirus (HPV), dat seksueel wordt overgedragen. Het KCE (Federaal Kenniscentrum voor de Gezondheidszorg) stelde, samen met het Wetenschappelijk Instituut Volksgezondheid (WIV) en het Kankerregister, vast dat een screening met de HPV-test, die het virus opspoort, vrouwen ouder dan 30 jaar beter beschermt tegen baarmoederhalskanker dan de klassieke uits...

    Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II

    282 p. ill;, LIST OF FIGURES 7 -- LIST OF TABLES 13 -- LIST OF ABBREVIATIONS .20 --  SCIENTIFIC REPORT .22 -- 1 OPTIMAL FIRST SCREENING TEST .22 -- 1.1 UPDATE ON ACCURACY OF HPV VS. CYTOLOGY SCREENING 22 -- 1.1.1 Introduction .22 -- 1.1.2 Methods.24 -- 1.1.3 Results 25 -- 1.1.4 Relative cross-sectional accuracy 36 -- 1.1.5 Cross-sectional outcomes of randomised trials comparing cytology with HPV based screening 39 -- 1.1.6 Discussion 41 -- 1.2 EFFICACY AND EFFECTIVENESS OF HPV V...

    Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II

    27 p. ill;, FOREWORD 1 -- ABSTRACT 2 -- SYNTHESIS 4 -- 1. INTRODUCTION 6 -- 1.1. BACKGROUND 6 -- 1.1.1. Incidence 6 -- 1.1.2. Mass screening 6 -- 1.1.3. Caused by HPV 6 -- 1.1.4. Pap test 6 -- 1.1.5. HPV test 7 -- 1.2. THE PROBLEM ADDRESSED BY THIS REPORT. 7 -- 2. FINDINGS 8 -- 2.1. WHAT IS THE OPTIMAL SCREENING ALGORITHM FOR CERVICAL CANCER SCREENING 8 -- 2.1.1. Update on accuracy of HPV vs. cytology screening 8 -- 2.1.2. Efficacy of HPV-based compared to cytology-based screening 8 -- ...

    Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis

    Abstract Background The purpose of this study was to validate the accuracy of an alternative cervical cancer test – visual inspection with acetic acid (VIA) – by addressing possible imperfections in the gold standard through latent class analysis (LCA). The data were originally collected at peri-urban health clinics in Zimbabwe. Methods Conventional accuracy (sensitivity/specificity) estimates for VIA and two other screening tests using colposcopy/biopsy as the reference standard were compare...
  • No person research data found

Share - Bookmark